Other
Cesarean Delivery
1
Pipeline Programs↗
15
Active Trials↗
2
Companies Involved↗
Cesarean Delivery is an early-stage landscape with 1 program across 2 companies. The most active players are Amring, BioQ Pharma, Inc..
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical
No programs
Phase 11
Phase 2
No programs
Phase 3
No programs
Approved
No programs
Analysis
Trial Status
118
clinical trials
Completed79 · 67%
Unknown status16 · 14%
Recruiting11 · 9%
Withdrawn5 · 4%
Terminated3 · 3%
Not yet recruiting2 · 2%
Other2 · 2%
Clinical Trials
Trial Activity
118 trials
Azithromycin Prophylaxis for PRElabor CEsarean DElivery Trial
Recruiting·TThe George Washington University Biostatistics Center·Phase 3·NCT06605118·8,000 enrolled
Norepinephrine With Ephedrine Versus Norepinephrine Alone During Spinal Anesthesia for Cesarean Delivery
Not yet recruiting·—·Phase 4·NCT07379710·260 enrolled
Page 1 of 8
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)